New approach aims to cut donor blood use in cancer operations
NCT ID NCT04922307
Summary
This study tests whether using a patient's own blood during kidney cancer surgery can reduce the need for donor blood transfusions. Researchers are comparing standard blood management against techniques that recycle or dilute the patient's blood during the operation. The goal is to lower transfusion-related risks and potentially improve recovery outcomes for 240 patients with advanced kidney cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Winship Cancer Institute at Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.